These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Renal tubular transport of methotrexate in the rhesus monkey and dog. Huang KC, Wenczak BA, Liu YK. Cancer Res; 1979 Dec; 39(12):4843-8. PubMed ID: 115582 [Abstract] [Full Text] [Related]
3. Some observations on the human pharmacology of methotrexate. Calvert AH, Bondy PK, Harrap KR. Cancer Treat Rep; 1977 Dec; 61(9):1647-56. PubMed ID: 597817 [Abstract] [Full Text] [Related]
4. Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model. Tamhane M, Chakilam AR, Jayaraj A, Thakkar V, Taft DR. Drug Dev Ind Pharm; 2010 Mar; 36(3):315-22. PubMed ID: 20170280 [Abstract] [Full Text] [Related]
10. Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension. Gewirtz DA, Plotkin JH, Randolph JK. Cancer Res; 1984 Sep; 44(9):3846-50. PubMed ID: 6744302 [Abstract] [Full Text] [Related]
12. Different inhibitory effects of 2,4-dinitrophenol, iodoacetate, and probenecid on renal excretion of p-aminohippurate, cyclopenthiazide, and sulfamethoxypyridazine in rats. Stopp M, Weise C, Mewes S, Bräunlich H. Acta Biol Med Ger; 1976 Sep; 35(6):787-92. PubMed ID: 983625 [Abstract] [Full Text] [Related]
14. Active transport of methotrexate from cerebrospinal fluid in humans. Bode U, Magrath IT, Bleyer WA, Poplack DG, Glaubiger DL. Cancer Res; 1980 Jul; 40(7):2184-7. PubMed ID: 7388786 [Abstract] [Full Text] [Related]
18. No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs. Kim SH, Kim WB, Lee MG. Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):85-92. PubMed ID: 9755846 [Abstract] [Full Text] [Related]